Blher M, Rosenstock J, Hoefler J, Manuel R, Hennige AM
Lack of provider oversight
For those comparing oral versus injectable options , the convenience factor is substantial
For patients on levothyroxine, TSH decreases during semaglutide treatment may indicate that thyroid medication doses need to be reduced not that the thyroid itself is being affected
Similar content being viewed by others 1 Introduction Significant challenges in obtaining sufficient systemic exposure of orally administered peptide- and protein-based drugs are due to the acidic environment and presence of proteolytic enzymes in the stomach, and the limited permeability of peptides and proteins through the gastrointestinal epithelium [1, 2]
Any intervention producing 15% weight loss in a year will stress the gallbladder